Join James Scull, Ph.D., Scientific Director for Element Life Sciences, to gain a deeper understanding of E&L evaluations of custom drug delivery devices.
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards